| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Champions Oncology, Inc. (CSBR) has 6 insiders with recent SEC Form 4 filings, including 12 buys and 2 sells. CSBR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 299.2K | $1.80M | - | |
| 10% | 25.5K | $153.3K | - | |
| Dir | 21.2K | $127.7K | - | |
| Dir | 21.2K | $127.7K | - | |
| Dir | 13.8K | $83.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2023 | Mendelson Daniel Newman55 | Director | Buy | 5,000 | $5.65 | $28,250.00 | +3.5% | -11.3% | -14.2% | |
| Sep 22, 2023 | Mendelson Daniel Newman55 | Director | Buy | 3,812 | $5.50 | $20,966.00 | +2.8% | -9.1% | -11.7% | |
| Sep 21, 2023 | Mendelson Daniel Newman55 | Director | Buy | 5,000 | $5.51 | $27,550.00 | +3.8% | -6.8% | -10.5% | |
| Sep 20, 2023 | Mendelson Daniel Newman55 | Director | Buy | 4,018 | $5.51 | $22,139.18 | +3.1% | -14.8% | -8.6% | |
| Sep 19, 2023 | Mendelson Daniel Newman55 | Director | Buy | 5,000 | $5.28 | $26,400.00 | +4.1% | -11.1% | -17.9% | |
| Mar 17, 2023 | Morris Ronnie | CEO | Buy | 12,382 | $4.04 | $49,968.80 | +1.5% | +37.7% | +36.7% | |
| Dec 16, 2020 | Breitfeld Philip P. | Director | Sell | 31,443 | $11.35 | $356,975.52 | -100% | - | - | |
| Mar 26, 2020 | Mendelson Daniel Newman55 | Director | Buy | 1,220 | $5.91 | $7,213.00 | +0.4% | - | - | |
| Mar 24, 2020 | Mendelson Daniel Newman55 | Director | Buy | 26 | $5.50 | $143.00 | - | - | - | |
| Mar 24, 2020 | Morris Ronnie | CEO | Sell | 75 | $5.25 | $393.75 | - | - | - |